Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Comparison of the BioFreedom Biolimus A9 Drug Coated Stent Versus the Gazelle Bare Metal Stent in Patients With High Risk of Bleeding.

NCT01623180 is registered in ClinicalTrials.gov with Biosensors Europe SA as lead sponsor.

NCT NCT01623180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01623180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Comparison of the BioFreedom Biolimus A9 Drug Coated Stent Versus the Gazelle Bare Metal Stent in Patients With High Risk of Bleeding.
Lead sponsor
Biosensors Europe SA
Phase
Not applicable
Overall status
Unknown status
Start date
December 31, 2012
Completion date
June 30, 2016
Enrollment
2,456 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding, in-stent coronary artery restenosis, ischemic heart disease silent, st elevation (stemi) and non-st elevation (nstemi) myocardial infarction, stable angina